Skip to content

Free cash flow at other companies

IAR
Integra LifeSciencesIART
-$5.05M+87.4%
MiMedx Group logo
MiMedx GroupMDXG
$1.31M-73.4%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$28.27M-12.5%
Bioventus logo
BioventusBVS
$8.36M+141%
Artivion logo
ArtivionAORT
-$6.85M+66.7%
Axogen logo
AxogenAXGN
-$1.22M+90.9%

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Organogenesis Holdings Inc.’s reported figures.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s free cash flow?
Organogenesis Holdings Inc. (ORGO) reported free cash flow of $17.98M in Q1 2026.
How has Organogenesis Holdings Inc.'s free cash flow changed year-over-year?
Organogenesis Holdings Inc.'s free cash flow increased by 176.3% year-over-year, from -$23.56M to $17.98M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.